TL;DR
- •Klonopin (clonazepam) has a longer half-life than Xanax (~18-50 hours vs 6-12 hours) — making it somewhat easier to taper but still subject to all the benzodiazepine-class risks including seizures with abrupt discontinuation.
- •Benzodiazepine withdrawal can be DANGEROUS — supervised tapering is essential. The Ashton Manual remains the foundational reference for benzodiazepine tapering protocols.
- •Klonopin's longer half-life means inter-dose withdrawal is less pronounced than with Xanax, so the "between-dose anxiety" cycle is less defining of the daily experience.
- •Tapers typically take 6-18 months for long-term users — much longer than antidepressant tapers, and longer than Xanax tapers because Klonopin's longer half-life still requires very-gradual proportional reductions.
- •For Klonopin patients with anxiety as the primary indication, ketamine offers an entirely different anxiolytic mechanism that can support the taper.
- •Compounded liquid clonazepam is available for very-fine dose reductions during the final stages of taper.
Why people decide to taper
- •Tolerance — the dose no longer produces the original anxiolytic effect
- •Cognitive side effects (memory, processing speed, concentration)
- •Concerns about long-term cognitive effects
- •Fall risk (particularly in older adults)
- •Original anxiety in remission or being managed by other means
- •Dependence concerns — wanting to be free of daily medication
- •Pregnancy planning (benzodiazepines have specific pregnancy concerns)
What withdrawal looks like
Klonopin withdrawal is somewhat smoother than Xanax withdrawal because of the longer half-life — symptoms typically begin 24-72 hours after the last dose rather than within hours. Common symptoms: anxiety rebound, insomnia, tremors, sweating, irritability, perceptual changes (heightened light/sound sensitivity, depersonalization), muscle tension, GI disturbance. Severe cases can include seizures, hallucinations, delirium. Like all benzodiazepines, Klonopin produces "kindling" — repeated withdrawal episodes can become progressively worse, making cold-turkey attempts particularly risky.
Typical taper timeline
Klonopin tapers are typically long. Short-term users (a few months): 3-6 months of taper. Long-term users (years): often 6-18 months for safe hyperbolic tapering. The longer half-life means each dose reduction settles over a longer timeframe — paradoxically this means waiting longer between reductions, not shorter.
Taper approaches
Options to bring to your prescriber. The dose-by-dose plan belongs to your prescriber, not this page.
Hyperbolic taper (recommended for benzodiazepines)
Smaller and smaller proportional reductions over months. The standard "reduce 0.25mg every 2 weeks" approach often produces significant withdrawal; reducing by 5-10% of current dose every 2-4 weeks is more tolerable.
Switch to Valium for taper
Some clinicians convert Klonopin to equivalent-dose Valium (diazepam) for the taper. Klonopin and Valium both have long half-lives, so the benefit is less dramatic than the Xanax-to-Valium switch — but Valium's broader range of dose strengths and liquid availability can help with fine reductions.
Liquid clonazepam
Compounded liquid clonazepam allows very-small dose reductions that the 0.5mg/1mg/2mg tablet strengths can't achieve. Essential for the final stages of hyperbolic taper.
Address underlying anxiety with ketamine
For Klonopin patients with anxiety as the primary indication, ketamine's NMDA mechanism offers a different anxiolytic pathway. The rapid anxiolytic effect of ketamine can support the breakthrough anxiety that often derails benzodiazepine tapers.
Ashton Manual approach
The Ashton Manual (Heather Ashton, 1999) remains the foundational reference for benzodiazepine tapering. Many specialized clinicians and patient communities use the protocols described there. Worth knowing about if you're embarking on a long benzodiazepine taper.
What’s specific to Klonopin (Clonazepam)
Klonopin's half-life of 18-50 hours is one of the longer benzodiazepine half-lives, only exceeded by Valium and a few others. This makes daily dosing simpler than Xanax and produces less inter-dose withdrawal. The longer half-life also means dose changes settle over days rather than hours — both an advantage (smoother kinetics) and a constraint (taper steps need to be spaced further apart). Klonopin is FDA-approved for panic disorder and certain seizure indications; many patients are on it for panic specifically. The 0.5mg/1mg/2mg tablet strengths become limiting for hyperbolic taper below 0.5mg — at which point liquid compounded formulations are typically used.
Where ketamine fits
For Klonopin patients with anxiety as the primary indication, ketamine offers an entirely different anxiolytic mechanism through NMDA receptor antagonism. The rapid anxiolytic effect (within hours of the first session) provides support for breakthrough anxiety during the benzodiazepine taper. Tovani screens for benzodiazepine-dependence status during consultation and coordinates with the patient's prescribing physician on taper timing. Many patients find that ketamine's episodic dosing pattern is preferable to chronic benzodiazepine use long-term — both for cognitive function and freedom from daily medication.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is Klonopin easier to come off than Xanax?
Generally yes, because of the longer half-life. Klonopin's 18-50 hour half-life produces smoother kinetics than Xanax's 6-12 hours, with less inter-dose withdrawal. But Klonopin tapers still require slow timelines and prescriber supervision — the dependence physiology is similar across benzodiazepines.
What is the Ashton Manual?
A foundational document on benzodiazepine tapering by Dr. Heather Ashton (1999), based on her decades of clinical experience helping benzodiazepine-dependent patients. Available freely online. Describes slow-taper protocols (often 12+ months) and benzodiazepine equivalence tables (used for the Valium-bridge approach). Many specialized clinicians and patient communities use these protocols.
How long is a realistic Klonopin taper?
Short-term users (a few months on the medication): 3-6 months of taper. Long-term users (years): often 6-18 months for safe, comfortable hyperbolic tapering. The longer half-life of Klonopin doesn't dramatically shorten the timeline relative to other benzodiazepines.
Can I take ketamine while still on Klonopin?
In many cases, yes — but the combination requires careful clinical coordination. Both medications produce sedation; the combination needs supervision. Tovani screens for benzodiazepine use during consultation and works with the patient's prescriber on whether ketamine therapy is appropriate during the active taper period or after some Klonopin reduction.
I take Klonopin for panic, not anxiety in general. Will ketamine still help?
Likely. Panic disorder responds to ketamine through the same NMDA-mediated anxiolytic mechanism that helps generalized anxiety. The clinical evidence is stronger for ketamine in treatment-resistant depression than in primary panic disorder, but many panic patients with comorbid depression or anxiety find substantial benefit.
Never taper without prescriber coordination
Withdrawal symptoms can mimic depression or anxiety relapse, and untreated relapse can be more dangerous than withdrawal. Stopping benzodiazepines abruptly can produce seizures. Bring this page to your prescriber as a conversation starter — they translate options into your specific plan.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — anxiety symptoms improved alongside core response, relevant for benzodiazepine-treated patients seeking alternatives. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine in mood and anxiety disorders — addresses use in patients with complex pharmacology including chronic benzodiazepine maintenance. PMID 28249076